The Safety and Efficacy of Lansoprazole plus Metoclopramide among Neonates with Gastroesophageal Reflux Disease Resistant to Conservative Therapy and Monotherapy: A Clinical Trial
Table 3
GERD-related clinical manifestation scoring, before and one week after intervention.
GERD clinical manifestations
preintervention
value
Mean one week after intervention
value
Ranitidine plus metoclopramide (group A)
Lansoprazole plus metoclopramide (group B)
Ranitidine plus metoclopramide (group A)
Lansoprazole plus metoclopramide (group B)
Weight
0.835
0.712
Vomiting intensity
0.835
0.041
Vomiting volume
0.912
0.288
Refusal feeding
0.781
0.332
Refusal feeding contrary being hungry
0.714
0.251
Crying before and after feeding
0.219
0.046
Crying duration
0.360
0.162
Hiccup
0.142
0.076
Arching
0.084
0.137
Vomiting associated with irritability and lethargy
